Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

CONTEXT: Opioid use disorders are a significant public health problem. In 2002, the FDA approved buprenorphine as an opioid use disorder treatment when prescribed by waivered physicians who were limited to treating 30 patients at a time. In 2006, federal legislation raised this number to 100 patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Milbank Q
Autors principals: STEIN, BRADLEY D, PACULA, ROSALIE LICCARDO, GORDON, ADAM J, BURNS, RACHEL M, LESLIE, DOUGLAS L, SORBERO, MARK J, BAUHOFF, SEBASTIAN, MANDELL, TODD W, DICK, ANDREW W
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2015
Matèries:
Original Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4567853/
https://ncbi.nlm.nih.gov/pubmed/26350930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1468-0009.12137
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars